Cure My Disease

Don't miss your cure!

 Log in / Sign up

Zapping the brain with microcurrents may curb cravings — a trial puts it to the test

NCT ID NCT07737652

Completed Symptom relief Sponsor: University of Alabama, Tuscaloosa Source: ClinicalTrials.gov ↗

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This pilot trial tests whether adding microcurrent neurofeedback (MCN) to standard residential treatment helps adults with substance use disorder more than standard care alone. MCN uses scalp sensors to deliver barely perceptible electrical pulses tailored to each person's brain activity. Researchers will measure changes in cravings, depression, anxiety, and PTSD symptoms over 12 weeks. The study also checks whether MCN is practical to use in a residential treatment setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a noninvasive device that delivers low-intensity electrical pulses to the scalp, called microcurrent neurofeedback (IASIS MCN)
What this could lead to
If it works, this could offer a drug-free way to reduce cravings and improve mental health during substance use treatment.
What could go wrong
This is a small pilot study, so results may not apply broadly. The device's effects on cravings and mood are still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Depression depressive disorder opiate dependence post-traumatic stress disorder substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DEPRESSION POST-TRAUMATIC STRESS DISORDER SUBSTANCE USE DISORDER (SUD)

Contacts and locations

Locations

  • Capstone College of Nursing, 650 University Blvd, 35401 Tuscaloosa

    Tuscaloosa, Alabama, 35401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.